Question for Vertex Bulls Is How to Build on a $20 Billion Rally

(Bloomberg) -- Vertex Pharmaceuticals Inc., on the brink of a breakthrough that could treat nearly all patients with cystic fibrosis, has done everything an investor could ask for in 2017, includin...